Ulrike Lueken
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (16)
Year:
2026
Psychedelic clinical research is expanding rapidly. This review analyses the state and trends in psychedelic clinical trial registrations. A systematic search of ClinicalTrials.Gov was conducted on 11 November 2024, to identify registered interventional trials investigating (therapeutic) effects of serotonergic psychedelics (e.g. lysergic acid diethylamide [LSD], psilocybin, [5-MeO-]DMT). Analyses included a negative binomial regression to assess time trends and descriptive summaries of study characteristics. Outcomes included registration trends, substance distribution, study phase progression, sample and trial characteristics, geographical distribution and psychotherapy reporting. A total of 241 trials were identified, with registrations rising exponentially after 2006 and an acceleration post-2019. Two-thirds of trials are ongoing or planned. Psilocybin remains the most frequently studied substance and is most advanced towards approval, but short-acting psychedelics ([5-MeO-]DMT) have recently been introduced with a more focused clinical scope. Industry involvement is increasing, though university-led research still dominates. Reports of psychotherapy components increased following 2023 FDA recommendations, though no major improvements in intervention descriptions were observed. The rapid expansion of registered psychedelic clinical trials with diverse indications and substances reflects growing clinical interest. While university-led studies initiated early investigations and established a broad knowledge base, later industry involvement increasingly prioritizes scalability and economic considerations by adopting a focused approach towards clinical approval. Inconsistent reporting of psychotherapeutic components limits cross-study comparability and complicates systematic investigations into which combinations of therapeutic elements (type, timing, intensity) may optimize clinical outcomes. Future efforts should focus on complete and standardized trial reporting at study registration to minimize bias, reduce interpretative ambiguity and facilitate cross-trial comparisons.
Year:
2026
Year:
2026
Year:
2026
Introduction Despite the established status of trauma-focused psychotherapy (TFP) as a first-line treatment for post-traumatic stress disorder (PTSD), a substantial proportion of individuals do not achieve clinically significant improvement or discontinue treatment. Exploring augmentation strategies to enhance treatment outcomes is essential to reduce the overall burden PTSD puts on individuals and society. This protocol outlines a systematic review and meta-analysis of randomised controlled trials (RCTs) evaluating the efficacy of non-pharmacological augmentation strategies in addition to TFP for PTSD treatment. Methods and Analysis We comprehensively searched PubMed, Embase, CENTRAL, PTSDpubs, PsycArticles, PsycINFO, PSYNDEX and CINAHL for RCTs without restrictions on publication dates or languages in October 2024. Study screening is currently ongoing. Additionally, we will perform forward and backward searches of the included studies and relevant reviews. Two reviewers will independently screen and select studies, extract data and assess the risk of bias. We will conduct a narrative review to qualitatively synthesise data and a meta-analysis to quantitatively compare the treatment efficacy of augmented TFP with TFP alone or TFP plus placebo. Primary outcomes will be both symptom severity and response rates. The secondary outcome will be dropout rates. We will explore sources of between-study heterogeneity and potential moderators through subgroup and meta-regression analyses. We will assess the overall quality of the included studies with the Grading of Recommendations Assessment, Development, and Evaluation system. Ethics and dissemination Ethical approval is not required. We intend to publish results in a peer-reviewed journal and provide materials and data through the Open Science Framework. PROSPERO registration number CRD42024549435.
Year:
2025
Background Chat-based counseling services are popular for the low-threshold provision of mental health support to youth. In addition, they are particularly suitable for the utilization of natural language processing (NLP) for improved provision of care. Objective Consequently, this paper evaluates the feasibility of such a use case, namely, the NLP-based automated evaluation of satisfaction with the chat interaction. This preregistered approach could be used for evaluation and quality control procedures, as it is particularly relevant for those services. Methods The consultations of 2609 young chatters (around 140,000 messages) and corresponding feedback were used to train and evaluate classifiers to predict whether a chat was perceived as helpful or not. On the one hand, we trained a word vectorizer in combination with an extreme gradient boosting (XGBoost) classifier, applying cross-validation and extensive hyperparameter tuning. On the other hand, we trained several transformer-based models, comparing model types, preprocessing, and over- and undersampling techniques. For both model types, we selected the best-performing approach on the training set for a final performance evaluation on the 522 users in the final test set. Results The fine-tuned XGBoost classifier achieved an area under the receiver operating characteristic score of 0.69 (P<.001), as well as a Matthews correlation coefficient of 0.25 on the previously unseen test set. The selected Longformer-based model did not outperform this baseline, scoring 0.68 (P=.69). A Shapley additive explanations explainability approach suggested that help seekers rating a consultation as helpful commonly expressed their satisfaction already within the conversation. In contrast, the rejection of offered exercises predicted perceived unhelpfulness. Conclusions Chat conversations include relevant information regarding the perceived quality of an interaction that can be used by NLP-based prediction approaches. However, to determine if the moderate predictive performance translates into meaningful service improvements requires randomized trials. Further, our results highlight the relevance of contrasting pretrained models with simpler baselines to avoid the implementation of unnecessarily complex models. Trial Registration Open Science Framework SR4Q9; https://osf.io/sr4q9
Year:
2025
Pavlovian fear conditioning is a fundamental process in both health and disease. We investigated its neural correlates and sources of variability using harmonized functional magnetic resonance imaging data from 2,199 individuals across nine countries, including 1,888 healthy individuals and 311 with anxiety-related or depressive disorders. Using mega-analysis and normative modelling, we show that fear conditioning consistently engages brain regions within the "central autonomic–interoceptive" or "salience" network. Several task variables strongly modulate activity in these regions, contributing to variability in neural responses. Additionally, brain activation patterns differ between healthy individuals and those with anxiety-related or depressive disorders, with distinct profiles characterizing specific disorders such as post-traumatic stress disorder and obsessive-compulsive disorder. While the neural correlates of fear conditioning are highly generalizable at the population level, variability arises from differences in task design and clinical status, highlighting the importance of methodological diversity in capturing fear learning mechanisms.
Year:
2025
Negative affect (NA)—encompassing heightened states of sadness, anxiety, and guilt—is a key symptom across a spectrum of internalizing disorders. Recent advancements in digital phenotyping (DP) and machine learning (ML) have raised hopes of automatically identifying short-term fluctuations in NA through digital phenotyping, a prerequisite for Just-In-Time Adaptive Interventions (JITAI). But evidence on the short-term prediction of NA states with passive DP data is sparse. In this preregistered study, we examined whether passive sensor data (heart rate, step count, GPS) and contextual information could predict short-term changes in NA in a sample of 158 outpatients with internalizing disorders. We systematically compared personalized ML approaches (i.e. mixed effect random forests) to population-based models (e.g., random forests) and two benchmark models (individual and population based average NA). We found that personalized ML approaches yielded substantial performance gains compared to population-based models. Nonetheless, the best models only marginally outperformed the benchmark predicting average NA per person. Our findings question the feasibility of detecting short term changes in NA based on completely passively collected sensor data. Future efforts could incorporate richer and/or more raw data streams or test sequential modelling approaches. This will help clarify whether DP and personalized ML can reliably deliver just-in-time, data-driven support for individuals with internalizing disorders.
Year:
2025
Chat-based counseling hotlines emerged as a promising low-threshold intervention for youth mental health. However, despite the resulting availability of large text corpora, little work has investigated Natural Language Processing (NLP) applications within this setting. Therefore, this preregistered approach (OSF: XA4PN) utilizes a sample of approximately 19,000 children and young adults that received a chat consultation from a 24/7 crisis service in Germany. Around 800,000 messages were used to predict whether chatters would contact the service again, as this would allow the provision of or redirection to additional treatment. We trained an XGBoost Classifier on the words of the anonymized conversations, using repeated cross-validation and bayesian optimization for hyperparameter search. The best model was able to achieve an AUROC score of 0.68 ( p < 0.01) on the previously unseen 3942 newest consultations. A shapely-based explainability approach revealed that words indicating younger age or female gender and terms related to self-harm and suicidal thoughts were associated with a higher chance of recontacting. We conclude that NLP-based predictions of recurrent contact are a promising path toward personalized care at chat hotlines.
Year:
2024
Theoretical Background: Increased mental health distress in children and families during the COVID-19 pandemic has been widely reported in studies. Aim: During the first year of the COVID-19 pandemic (i. e., 2020 – 2021), we examined a help-seeking sample for child distress and the associations with parent distress, quality of life, and COVID-19-specific factors, aiming to describe families seeking help. Method: We conducted an online survey in help-seeking families ( N = 169, children aged 5 – 17 years). Results: Children’s anxiety and depression did not exceed clinical cutoffs but quality of life did. Only parental and child depressiveness were related. Child emotion regulation was shown to be the only relevant predictor of child anxiety, depressive symptoms, and quality of life, whereas no parental or COVID-19-related factors reached significance. Discussion and Conclusion: Specifics of our help-seeking sample differed from other COVID-19 studies, highlighting the relevance of taking a closer look at specific samples to provide custom-fit support.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (50)
Henrik Walter
Charité - Universitätsmedizin Berlin
Katja Koelkebeck
Professor, Senior psychiatrist
Bielefeld University, Medical School and University Medical Center OWL
Renee Visser
Academic, Assistant Professor
University of Amsterdam
Christine Knaevelsrud
Freie Universität Berlin
Carien M. van Reekum
University of Reading
Jayne Morriss
University of Southampton
Kevin Hilbert
Professor
Health and Medical University Erfurt
Katie McLaughlin
Professor of Psychology
Harvard University
Joscha Böhnlein
Teaching Psychotherapist
University of Münster
Norbert Kathmann
Professor
Humboldt-Universität zu Berlin
Andre Pittig
University of Göttingen
Christian J. Merz
Ruhr-Universität Bochum
Miguel Fullana
Consultant Clinical Psychologist/Senior Researcher
Hospital Clínic de Barcelona
Annette Brose
Max Planck Institute for Human Development
Markus Junghoefer
Professor
Westfälische Wilhelms-Universität Münster
Manuel Kuhn
Senior Researcher
Charité - Universitätsmedizin Berlin
Steven Greening
Associate Professor
University of Manitoba
Andreas Reif
Chair
Goethe University Frankfurt
Jonathan Repple
Professor and senior managing physician
University Hospital Frankfurt
Fredrik Åhs
Associate Professor at Mid Sweden University
Mid Sweden University
Nynke A Groenewold
Associate Professor
University of Cape Town
Marta Cano
Ramón y Cajal Researcher – Head of the Imaging for Precision Psychiatry Research Line
Institut de Recerca Sant Pau
Samuel Cooper
Assistant Professor
University of Texas at Austin
Janna Marie Bas-Hoogendam
Assistant professor
Leiden University
Julia Asbrand
Professor
Friedrich Schiller University Jena
Udo Dannlowski
University of Münster
Andreas Keil
Distinguished Professor
University of Florida
Drin Ferizaj
Charité - Universitätsmedizin Berlin
Martin Ulrich
Ulm University
Tilo Kircher
Professor, Chair
University of Marburg
Marcel Romanos
Head of department
Universitätsklinikum Würzburg
Jan Richter
University of Hildesheim
Daphne J. Holt
Director, Resilience and Prevention Program; Co-Director, Psychosis Clinical and Research Program; Associate Professor, Harvard Medical School
Massachusetts General Hospital
Christine Larson
Professor
University of Wisconsin-Milwaukee
Winfried Rief
Professor of Clinical Psychology
University of Marburg
Matthias Gamer
Professor for Experimental Clinical Psychology
Julius-Maximilians-Universität Würzburg
Xi Zhu
Assistant Professor
Columbia University Irving Medical Center
Martin J Herrmann
University Hospital Würzburg
Joaquim Radua
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Benjamin Straube
Professor for Translational Neuroimaging
Philipps-Universität Marburg
M. Lotze
University of Greifswald
Kerstin Ritter (née Hackmack)
Junior professor for Computational Neuroscience
Charité - Universitätsmedizin Berlin
Dan Stein
Professor and Chair of Psychiatry
University of Cape Town
Ashley A Huggins
Assistant Professor
University of Arizona
Tina Lonsdorf
Professorin
Bielefeld University
Joseph Dunsmoor
University of Texas at Austin
Babette Renneberg
Professor
Freie Universität Berlin
Miriam Schiele
Full Professor and Chair
Technische Universität Dresden
Tom Beckers
Professor of Psychology
KU Leuven
Dominik R. Bach
Hertz Chair for Artificial Intelligence and Neuroscience
University of Bonn
Make your next move.
Prepare your application
Review drafts before you send them.